Cite

HARVARD Citation

    Stanley, T. et al. (2019). Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet. 6 (12), pp. e821-e830. [Online]. 
  
Back to record